Dr. Olivier Brass earned a Ph.D. in 1992 from University of Lyon, Fr , in the biophysical and molecular interaction field in collaboration with Industrial and Academic partners (CNRS, INSERM and INSA labs).
He worked with different Pharma and Biotech companies focusing on pharmaceutically active proteins. This included responsibilities in Research, Development, Quality control and Industrial Operation of API formulation (molecules, recombinant and purified proteins, and microorganisms).
In 2001 he joined Sanofi Pasteur, Marcy l’Etoile, Fr, where he held various positions as project leader and team manager in R and IO.
Since 2006, he had focussed on Formulation project from R&D to IO and specifically international corporate project for Vaccine stability prediction and stabilisation strategies for regulatory purposes.
He led several initiatives enabling the formulation of different kind of vaccines (molecular, macromolecular, particle adjuvant, splitt and lived attenuated virus).